Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.4K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perinatal Semaglutide Treatment Improves Maternal Health and Mitigates Offspring Metabolic Dysfunction in a Mouse Model of Maternal Obesity.

bioRxiv : the preprint server for biology·2026
Same author

Pediatric Risk Mapping From Co-Exposure to Extreme Temperatures and Air Pollutants.

GeoHealth·2026
Same author

Multi-omic profiling of early pregnancy small and large plasma extracellular vesicles reveals placental, metabolic, and structural adaptation signatures.

bioRxiv : the preprint server for biology·2026
Same author

Altered gene expression and activity of human placental drug-metabolizing cytochrome P450 enzymes across gestation.

Biochemical pharmacology·2026
Same author

The Effect of Intrauterine Growth Restriction on the Developing Pancreatic Immune System.

Endocrinology·2026
Same author

Maternal Exercise Rescues Fetal Akinesia-Impaired Joint and Bone Development.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025

Related Experiment Video

Updated: Nov 19, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.1K

Immune dysfunction in developmental programming of type 2 diabetes mellitus.

Thea N Golden1,2, Rebecca A Simmons3,4,5

  • 1Center for Research on Reproduction and Women's Health, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA, USA.

Nature Reviews. Endocrinology
|February 2, 2021
PubMed
Summary

Intrauterine growth restriction (IUGR) increases offspring type 2 diabetes mellitus (T2DM) risk. Immune system changes in fetal development, particularly pancreatic macrophages, contribute to this increased risk.

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.1K
Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
09:33

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

9.3K

Related Experiment Videos

Last Updated: Nov 19, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

17.1K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.1K
Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro
09:33

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

9.3K

Area of Science:

  • Immunology
  • Endocrinology
  • Developmental Biology

Background:

  • Intrauterine growth restriction (IUGR) is a pregnancy complication linked to later-life type 2 diabetes mellitus (T2DM) in offspring.
  • Immune system dysregulation during fetal development is a key factor in IUGR-associated T2DM pathogenesis.
  • Fetal immune system development requires balancing maternal tolerance with post-birth adaptation, and is vulnerable to intrauterine environmental changes.

Purpose of the Study:

  • To investigate the role of immune system alterations, specifically pancreatic macrophages, in the development of T2DM following IUGR.
  • To explore the impact of the intrauterine environment on fetal immune cell development and islet homeostasis.
  • To identify specific immune pathways and molecular changes in the islets of individuals with a history of IUGR.

Main Methods:

  • Analysis of immune cell populations, particularly macrophages, within the fetal pancreas.
  • Assessment of cytokine profiles (e.g., IL-1β, IL-4) and signaling pathways (e.g., TGFβ) in pancreatic islets.
  • Measurement of hormonal factors like leptin in the context of IUGR and immune activation.

Main Results:

  • Pancreatic-resident macrophages play a dynamic role in islet development, influencing β-cell proliferation and neogenesis.
  • Altered immune pathways, including changes in IL-1β, IL-4, TGFβ signaling, and leptin levels, are observed in the islets of individuals with IUGR.
  • Perturbations in islet homeostasis due to immune dysregulation can lead to islet dysfunction.

Conclusions:

  • Immune system alterations, particularly involving pancreatic macrophages and inflammatory mediators, are critically involved in the pathogenesis of IUGR-induced T2DM.
  • Understanding these immune mechanisms offers potential therapeutic targets for preventing or treating T2DM in individuals affected by IUGR.
  • Immunomodulatory strategies may hold promise as a therapeutic approach for IUGR-associated T2DM.